Sana Biotechnology, Inc. Common Stock (SANA)
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
- Headquarters
- United States
- Employees
- 142
- Market Cap
- $904M
About Sana Biotechnology, Inc. Common Stock
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates comprises SC291, SC262, UP421, and others.
SentiSense also tracks daily options readings for Sana Biotechnology, Inc. Common Stock: IV rank, put/call percentile, 25-delta skew, open-interest walls, and unusually active contracts, each measured against the stock's own history. Sign in to view them.
Sana Biotechnology, Inc. Common Stock stock analysis, sentiment tracking, and market intelligence on SentiSense.